lunes, 31 de enero de 2022

US COVID-19 Cases Falling, Hospitalizations Peaking

US COVID-19 Cases Falling, Hospitalizations Peaking

New AAD Guidelines on Atopic Dermatitis Comorbidities Available

New AAD Guidelines on Atopic Dermatitis Comorbidities Available

Omicron Subvariant 1.5 Times More Contagious Than Omicron

Omicron Subvariant 1.5 Times More Contagious Than Omicron

Long COVID Is Real, and Many Real Questions Remain

Long COVID Is Real, and Many Real Questions Remain

Trial tests strategy to augment response to COVID-19 vaccines in transplant recipients | National Institutes of Health (NIH)

Trial tests strategy to augment response to COVID-19 vaccines in transplant recipients | National Institutes of Health (NIH)

Could bird flu be the next world crisis? - ISRAEL21c

Could bird flu be the next world crisis? - ISRAEL21c

Now psychedelics are coming to your medicine cabinet - ISRAEL21c

Now psychedelics are coming to your medicine cabinet - ISRAEL21c

Revolutionary implant could ease congestive heart failure - ISRAEL21c

Revolutionary implant could ease congestive heart failure - ISRAEL21c

Keto diet may reduce damage from traumatic brain injury - ISRAEL21c

Keto diet may reduce damage from traumatic brain injury - ISRAEL21c

Scientists discover the mechanism that causes nerve destruction in ALS - ISRAEL21c

Scientists discover the mechanism that causes nerve destruction in ALS - ISRAEL21c

The answer to Parkinson’s and Alzheimer’s is all in your eyes - ISRAEL21c

The answer to Parkinson’s and Alzheimer’s is all in your eyes - ISRAEL21c

Why I got the fourth Covid-19 shot, despite my ambivalence - ISRAEL21c

Why I got the fourth Covid-19 shot, despite my ambivalence - ISRAEL21c

Experts agree it’s a bad idea to try and catch Covid-19 - ISRAEL21c

Experts agree it’s a bad idea to try and catch Covid-19 - ISRAEL21c

Israel finds 4th vaccine dose not as effective vs. Omicron - ISRAEL21c

Israel finds 4th vaccine dose not as effective vs. Omicron - ISRAEL21c

‘Stealth’ variant no cause for alarm, but could slow Covid-19 case decline | World News,The Indian Express

‘Stealth’ variant no cause for alarm, but could slow Covid-19 case decline | World News,The Indian Express

domingo, 30 de enero de 2022

Study Design for an Evaluation of Newborn Screening for SCID in the UK. Elliman David et al. International journal of neonatal screening 2022 8(1)

Main|Search|PHGKB

Using Genomic Epidemiology to Advance Public Health Action CDC Preventive Medicine Grand Rounds, February 22, 2022

Main|Search|PHGKB

New antisense oligonucleotide therapies reach first base in ALS A Lopez, Nature Medicine, January 24, 2022

Main|Search|PHGKB

Harnessing big data to characterize immune-related adverse events Y Jing et al, Nat Rev Clin Oncology, January 2022

Main|Search|PHGKB

Understanding microbiome alterations in autism K O'Leary, Nature Medicine, January 2022

Main|Search|PHGKB

A blood test to predict pre‑eclampsia K O'Leary, Nature Medicine, January 2022

Main|Search|PHGKB

Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia. Lee Shawn H R et al. JAMA oncology 2022 1

Main|Search|PHGKB

Man whose genetic condition went undiagnosed for 36 years is awarded £2.5m. Thornton Jacqui et al. BMJ (Clinical research ed.) 2022 1 o238

Main|Search|PHGKB

Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits. Schrijver Lieske H et al. Journal of the National Cancer Institute 2022 1

Main|Search|PHGKB

Healthcare-associated COVID-19 across 3 pandemic waves: patient characterisation and validation of clinical definitions using genome sequencing T Demuyser et al, Research Square, January 28, 2022

Main|Search|PHGKB

Specific PHGKB|Diabetes PHGKB|PHGKB

Specific PHGKB|Diabetes PHGKB|PHGKB

Specific PHGKB|Cancer|PHGKB

Specific PHGKB|Cancer|PHGKB

CDC-Authored Publications Update|PHGKB

CDC-Authored Publications Update|PHGKB

Precision Health Database| Non-Genomics Precision Health Weekly Scan|PHGKB

Precision Health Database| Non-Genomics Precision Health Weekly Scan|PHGKB

Advanced Molecular Detection Clips Database|AMD Clips|PHGKB

Advanced Molecular Detection Clips Database|AMD Clips|PHGKB

Precision Health Database| Genomics Precision Health Weekly Scan|PHGKB

Precision Health Database| Genomics Precision Health Weekly Scan|PHGKB

COVID-19 CDC Publications Database

COVID-19 CDC Publications Database

Severe COVID-19 in pregnancy is almost exclusively limited to unvaccinated women – time for policies to change - The Lancet Regional Health – Europe

Severe COVID-19 in pregnancy is almost exclusively limited to unvaccinated women – time for policies to change - The Lancet Regional Health – Europe

Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial - eClinicalMedicine

Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial - eClinicalMedicine

Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial - eBioMedicine

Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial - eBioMedicine

Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study - eBioMedicine

Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study - eBioMedicine

Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: A cohort study - eBioMedicine

Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: A cohort study - eBioMedicine

Novel COVID-19 therapies: the road ahead for rheumatology - The Lancet Rheumatology

Novel COVID-19 therapies: the road ahead for rheumatology - The Lancet Rheumatology

Tracing and vaccinating: how to REACT to COVID-19 pandemic - The Lancet Respiratory Medicine

Tracing and vaccinating: how to REACT to COVID-19 pandemic - The Lancet Respiratory Medicine

SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys - The Lancet Respiratory Medicine

SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys - The Lancet Respiratory Medicine

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries - The Lancet Microbe

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries - The Lancet Microbe

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial - The Lancet Microbe

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial - The Lancet Microbe

COVID-19 vaccine: what are we doing and what should we do? - The Lancet Infectious Diseases

COVID-19 vaccine: what are we doing and what should we do? - The Lancet Infectious Diseases

Persistence of protection against SARS-CoV-2 clinical outcomes up to 9 months since vaccine completion: a retrospective observational analysis in Lombardy, Italy - The Lancet Infectious Diseases

Persistence of protection against SARS-CoV-2 clinical outcomes up to 9 months since vaccine completion: a retrospective observational analysis in Lombardy, Italy - The Lancet Infectious Diseases

Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study - The Lancet Infectious Diseases

Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study - The Lancet Infectious Diseases

High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19 - The Lancet

High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19 - The Lancet

Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial - The Lancet

Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial - The Lancet

Boosting immunity after CoronaVac - The Lancet

Boosting immunity after CoronaVac - The Lancet

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - The Lancet

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - The Lancet

viernes, 28 de enero de 2022

A synthesis of evidence sheds light on major immune components and mechanisms involved in COVID-19

A synthesis of evidence sheds light on major immune components and mechanisms involved in COVID-19

New Wearable Device Could Help Prevent Overdose Deaths

New Wearable Device Could Help Prevent Overdose Deaths

Ischemic Stroke Rates Higher in Young Women Than Young Men

Ischemic Stroke Rates Higher in Young Women Than Young Men

Uptake Uncertain for Potent New Cholesterol-Lowerer Inclisiran

Uptake Uncertain for Potent New Cholesterol-Lowerer Inclisiran

'Super Immunity' Same Whether COVID-19 or Vaccination Comes First

'Super Immunity' Same Whether COVID-19 or Vaccination Comes First

For skin microbiome explorer Julie Segre, her quest is more than skin deep

For skin microbiome explorer Julie Segre, her quest is more than skin deep

Topographic diversity of fungal and bacterial communities in human skin - PubMed

Topographic diversity of fungal and bacterial communities in human skin - PubMed

COVID-19 Around the world weekly highlights: Omicron felt across the world, mandatory vaccination and 4th dose...

COVID-19 Around the world weekly highlights: Omicron felt across the world, mandatory vaccination and 4th dose...

COVID-19 vaccine: new data on waning effectiveness

COVID-19 vaccine: new data on waning effectiveness

One in 10 people with COVID-19 may be infectious for >10 days

One in 10 people with COVID-19 may be infectious for >10 days

COVID-19: true hypogeusia found in less than half of long-COVID cases

COVID-19: true hypogeusia found in less than half of long-COVID cases

New metabolic phenotype of long COVID identified

New metabolic phenotype of long COVID identified

Mix-and-Match Trial Finds Additional Dose of COVID-19 Vaccine Safe, Immunogenic | NIH: National Institute of Allergy and Infectious Diseases

Mix-and-Match Trial Finds Additional Dose of COVID-19 Vaccine Safe, Immunogenic | NIH: National Institute of Allergy and Infectious Diseases

HLA Gene May Predict if Cancer Immunotherapy Will Work - National Cancer Institute

HLA Gene May Predict if Cancer Immunotherapy Will Work - National Cancer Institute

ICYMI: New report demonstrates growing global impact of antimicrobial resistance

ICYMI: New report demonstrates growing global impact of antimicrobial resistance

New data show continued decline in death rates for cancer patients related to treatment advances

New data show continued decline in death rates for cancer patients related to treatment advances

New Links on MedlinePlus

New Links on MedlinePlus

Bruising | Hyperthyroidism | Encouraging Exercise | Weather Extremes | Blood Donation

Bruising | Hyperthyroidism | Encouraging Exercise | Weather Extremes | Blood Donation

Hip surveillance helps identify dislocations in children with cerebral palsy - Children's National

Hip surveillance helps identify dislocations in children with cerebral palsy - Children's National

GABA and glutamate in the preterm neonatal brain - Children's National

GABA and glutamate in the preterm neonatal brain - Children's National

Advancing immunotherapy for pediatric brain tumors - Children's National

Advancing immunotherapy for pediatric brain tumors - Children's National

Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19 | National Institutes of Health (NIH)

Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19 | National Institutes of Health (NIH)

jueves, 27 de enero de 2022

New method quickly, efficiently removes toxins from water - ISRAEL21c

New method quickly, efficiently removes toxins from water - ISRAEL21c

Gut inflammation? You might not need that colonoscopy - ISRAEL21c

Gut inflammation? You might not need that colonoscopy - ISRAEL21c

Israel Health Ministry: 4th Pfizer dose protects seniors - ISRAEL21c

Israel Health Ministry: 4th Pfizer dose protects seniors - ISRAEL21c

Sewage is an early-warning system for Covid outbreaks - ISRAEL21c

Sewage is an early-warning system for Covid outbreaks - ISRAEL21c

Experts agree it’s a bad idea to try and catch Covid-19 - ISRAEL21c

Experts agree it’s a bad idea to try and catch Covid-19 - ISRAEL21c

Patients need to pay less for their medicines. States can help.

Patients need to pay less for their medicines. States can help.

Stealth Omicron: All you need to know about the new ‘sub-strain’ of the Covid variant | Lifestyle News,The Indian Express

Stealth Omicron: All you need to know about the new ‘sub-strain’ of the Covid variant | Lifestyle News,The Indian Express

New research: 4 factors that may increase chances of long Covid | Explained News,The Indian Express

New research: 4 factors that may increase chances of long Covid | Explained News,The Indian Express

Quixplained: With 53 mutations, how Omicron defied the rules of evolution | Explained News,The Indian Express

Quixplained: With 53 mutations, how Omicron defied the rules of evolution | Explained News,The Indian Express

Long-COVID symptoms less likely in vaccinated people, Israeli data say

Long-COVID symptoms less likely in vaccinated people, Israeli data say

Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ®)–Health Professional Version - National Cancer Institute

Planning the Transition to End-of-Life Care in Advanced Cancer (PDQ®)–Health Professional Version - National Cancer Institute

Cervical Cancer Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Cervical Cancer Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Chronic Myelogenous Leukemia Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Chronic Myelogenous Leukemia Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Breast Cancer Treatment (Adult) (PDQ®)–Health Professional Version - National Cancer Institute

Breast Cancer Treatment (Adult) (PDQ®)–Health Professional Version - National Cancer Institute

Cancer Prevention and Screening: Progress Made and Progress to Come

CC News Alert: Top CC News Stories of 2021

CC News Alert: Top CC News Stories of 2021

Advanced Cancer Causes Money Problems, Even for the Insured - National Cancer Institute

Advanced Cancer Causes Money Problems, Even for the Insured - National Cancer Institute

Teen Depression

Teen Depression

What is an Opportunistic Infection? | NIH

What is an Opportunistic Infection? | NIH

Opportunistic Infection (OI) | NIH

Opportunistic Infection (OI) | NIH

NIAID Mouse Study Shows Existing Drug Could Limit COVID-19 Lung Damage | NIH: National Institute of Allergy and Infectious Diseases

NIAID Mouse Study Shows Existing Drug Could Limit COVID-19 Lung Damage | NIH: National Institute of Allergy and Infectious Diseases

Mix-and-match trial finds additional dose of COVID-19 vaccine safe, immunogenic | National Institutes of Health (NIH)

Mix-and-match trial finds additional dose of COVID-19 vaccine safe, immunogenic | National Institutes of Health (NIH)

Children and the Use of Complementary Health Approaches | NCCIH

Children and the Use of Complementary Health Approaches | NCCIH

miércoles, 26 de enero de 2022

Third dose of BNT162b2 vaccine protects against Omicron hospitalizations

Third dose of BNT162b2 vaccine protects against Omicron hospitalizations

Heterologous vaccine schedule provides extraordinary response to third dose of coronavirus vaccines

Heterologous vaccine schedule provides extraordinary response to third dose of coronavirus vaccines

Beta-amyloid deposits found in young patients with COVID-19

Beta-amyloid deposits found in young patients with COVID-19

Link established between gut microbiota and chronic inflammatory diseases

Link established between gut microbiota and chronic inflammatory diseases

How long does COVID-19 remain traceable on food?

How long does COVID-19 remain traceable on food?

Evaluating the use of megadoses of corticosteroids as a treatment of COVID-19

Evaluating the use of megadoses of corticosteroids as a treatment of COVID-19

PFAS found in high levels in anti-fogging sprays

PFAS found in high levels in anti-fogging sprays

NCI Support for Basic Science Paves Way for Kidney Cancer Drug Belzutifan – NIH Director's Blog

NCI Support for Basic Science Paves Way for Kidney Cancer Drug Belzutifan – NIH Director's Blog

NIH study classifies vision loss and retinal changes in Stargardt disease | National Institutes of Health (NIH)

NIH study classifies vision loss and retinal changes in Stargardt disease | National Institutes of Health (NIH)

Lichen Sclerosus: Treatment, Symptoms & Causes

Lichen Sclerosus: Treatment, Symptoms & Causes

Measuring protection after COVID-19 vaccination | National Institutes of Health (NIH)

Measuring protection after COVID-19 vaccination | National Institutes of Health (NIH)

Viagra associated with reduced risk of Alzheimer’s disease | National Institutes of Health (NIH)

Viagra associated with reduced risk of Alzheimer’s disease | National Institutes of Health (NIH)

COVID-19 vaccines linked to small increase in menstrual cycle length | National Institutes of Health (NIH)

COVID-19 vaccines linked to small increase in menstrual cycle length | National Institutes of Health (NIH)

E-cigarette use may lead some to quit traditional cigarettes | National Institutes of Health (NIH)

E-cigarette use may lead some to quit traditional cigarettes | National Institutes of Health (NIH)

Fiber in diet linked to cancer immunotherapy response | National Institutes of Health (NIH)

Fiber in diet linked to cancer immunotherapy response | National Institutes of Health (NIH)

SARS-CoV-2 infection of the inner ear | National Institutes of Health (NIH)

SARS-CoV-2 infection of the inner ear | National Institutes of Health (NIH)

Radiation Therapy for Bone Metastases | Effective Health Care (EHC) Program

Radiation Therapy for Bone Metastases | Effective Health Care (EHC) Program

New research: A portable, non-invasive way to detect oral cancer | Explained News,The Indian Express

New research: A portable, non-invasive way to detect oral cancer | Explained News,The Indian Express

Experiencing brain fog after Covid? It could be due to virus’ effect on spinal fluid, new study suggests | Lifestyle News,The Indian Express

Experiencing brain fog after Covid? It could be due to virus’ effect on spinal fluid, new study suggests | Lifestyle News,The Indian Express

martes, 25 de enero de 2022

Updated CPR Guidance Amidst Omicron Surge

Updated CPR Guidance Amidst Omicron Surge

Two Studies Show Omicron's Immune-Evasive Power, Role of Boosters

Two Studies Show Omicron's Immune-Evasive Power, Role of Boosters

Now that science has defanged Covid, it’s time to get on with our lives | Devi Sridhar | The Guardian

Now that science has defanged Covid, it’s time to get on with our lives | Devi Sridhar | The Guardian

Post-acute neurological consequences of COVID-19: an unequal burden | Nature Medicine

Post-acute neurological consequences of COVID-19: an unequal burden | Nature Medicine

COVID-19 Therapeutics for Nonhospitalized Patients | Infectious Diseases | JAMA | JAMA Network

COVID-19 Therapeutics for Nonhospitalized Patients | Infectious Diseases | JAMA | JAMA Network

Five things to know about fluvoxamine for symptomatic outpatients with COVID-19

Five things to know about fluvoxamine for symptomatic outpatients with COVID-19

COVID-19 will continue but the end of the pandemic is near - The Lancet

COVID-19 will continue but the end of the pandemic is near - The Lancet

Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US | HIV | JAMA Internal Medicine | JAMA Network

Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US | HIV | JAMA Internal Medicine | JAMA Network

COVID infection severity in children under 5 years old before and after Omicron emergence in the US | medRxiv

COVID infection severity in children under 5 years old before and after Omicron emergence in the US | medRxiv

Covid-19 vaccines and treatments: we must have raw data, now | The BMJ

Covid-19 vaccines and treatments: we must have raw data, now | The BMJ

Coronavirus (COVID-19) Update: FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant | FDA

Coronavirus (COVID-19) Update: FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant | FDA

Explained: Can your ancestors’ smoking habits have harmful effects on your health? | Explained News,The Indian Express

Explained: Can your ancestors’ smoking habits have harmful effects on your health? | Explained News,The Indian Express

Social connectedness, sleep, and physical activity associated with better mental health among youth during the COVID-19 pandemic | National Institutes of Health (NIH)

Social connectedness, sleep, and physical activity associated with better mental health among youth during the COVID-19 pandemic | National Institutes of Health (NIH)

Silencing a faulty gene may uncover clues to rare forms of ALS | National Institutes of Health (NIH)

Silencing a faulty gene may uncover clues to rare forms of ALS | National Institutes of Health (NIH)

Dangerous environmental neurotoxins are on the rise and climate change could make it worse. Can anything be done? - Genetic Literacy Project

Dangerous environmental neurotoxins are on the rise and climate change could make it worse. Can anything be done? - Genetic Literacy Project

What's New in the Guidelines? | NIH

What's New in the Guidelines? | NIH

COVID-19 Treatment Guidelines

COVID-19 Treatment Guidelines Dear International Colleague, As we have throughout the COVID-19 pandemic, the U.S. Food and Drug Administration has used the best available science as the virus has evolved to make informed decisions with the health and safety of the American public in mind. Ensuring that healthcare providers on the frontlines have the best tools available to treat patients is a top priority for the agency. In light of the most recent information and data available, today, the FDA revised the authorizations for two monoclonal antibody treatments – bamlanivimab and etesevimab (administered together) and REGEN-COV (casirivimab and imdevimab) – to limit their use to only when the patient is likely to have been infected with or exposed to a variant that is susceptible to these treatments. Because data show these treatments are highly unlikely to be active against the omicron variant, which is circulating at a very high frequency throughout the United States, these treatments are not authorized for use in any U.S. states, territories, and jurisdictions at this time. In the future, if patients in certain geographic regions are likely to be infected or exposed to a variant that is susceptible to these treatments, then use of these treatments may be authorized in these regions. Monoclonal antibodies are laboratory-made proteins that mimic the immune system's ability to fight off harmful pathogens such as viruses, like SARS-CoV-2. And like other infectious organisms, SARS-CoV-2 can mutate over time, resulting in certain treatments not working against certain variants such as omicron. This is the case with these two treatments for which we're making changes today. Based on Centers for Disease Control and Prevention data, the omicron variant of SARS-CoV-2 is estimated to account for more than 99% of cases in the United States as of Jan. 15. Therefore, it's highly unlikely that COVID-19 patients seeking care in the U.S. at this time are infected with a variant other than omicron, and these treatments are not authorized to be used at this time. This avoids exposing patients to side effects, such as injection site reactions or allergic reactions, which can be potentially serious, from specific treatment agents that are not expected to provide benefit to patients who have been infected with or exposed to the omicron variant. The NIH COVID-19 Treatment Guidelines Panel, an independent panel of national experts, recently recommended against the use of bamlanivimab and etesevimab (administered together) and REGEN-COV (casirivimab and imdevimab) because of markedly reduced activity against the omicron variant and because real-time testing to identify rare, non-omicron variants is not routinely available. Importantly, there are several other therapies – Paxlovid, sotrovimab, Veklury (remdesivir), and molnupiravir – that are expected to work against the omicron variant, and that are authorized or approved to treat patients with mild-to-moderate COVID-19 who are at high risk for progression to severe disease, including hospitalization or death. Healthcare providers should consult the NIH panel's COVID-19 treatment guidelines and assess whether these treatments are right for their patients. While it's critical that we have ways to treat those who contract COVID-19, the authorized treatments are not a substitute for vaccination in individuals for whom COVID-19 vaccination and a booster dose are recommended. Data has clearly demonstrated that the available, safe and effective vaccines can lower your risk of developing COVID-19 and experiencing the potential associated serious disease progression, including hospitalization and death. The FDA is committed to continuing to review emerging data on all COVID-19 therapies related to the potential impact of variants and revise the authorizations further as appropriate to ensure healthcare providers have an effective arsenal of treatments for patients.

COVID-19 Vaccines | FDA

COVID-19 Vaccines | FDA

CDC COVID Data Tracker

CDC COVID Data Tracker

Emergency Use Authorization | FDA

Emergency Use Authorization | FDA

lunes, 24 de enero de 2022

International Journal of Mental Health Systems | Home page

International Journal of Mental Health Systems | Home page

Italian Journal of Pediatrics | Home page

Italian Journal of Pediatrics | Home page

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine | Home page

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine | Home page

The Journal of Headache and Pain | Home page

The Journal of Headache and Pain | Home page

Translational Medicine Communications | Home page

Translational Medicine Communications | Home page

Trials | Home page

Trials | Home page

World Journal of Emergency Surgery | World society of emergency surgery

World Journal of Emergency Surgery | World society of emergency surgery

World Journal of Surgical Oncology | Home page

World Journal of Surgical Oncology | Home page

Journal of Eating Disorders | Home page

Journal of Eating Disorders | Home page

BMC Psychology | Home page

BMC Psychology | Home page

Orphanet Journal of Rare Diseases | Home page

Orphanet Journal of Rare Diseases | Home page

Nutrition alert: Avoid these foods for better immunity | Lifestyle News,The Indian Express

Nutrition alert: Avoid these foods for better immunity | Lifestyle News,The Indian Express

Unvaccinated women with COVID are more likely to lose fetuses and infants, Scottish data shows | Lifestyle News,The Indian Express

Unvaccinated women with COVID are more likely to lose fetuses and infants, Scottish data shows | Lifestyle News,The Indian Express

Covid-19: Advisory for safe home isolation amid Omicron wave | Lifestyle News,The Indian Express

Covid-19: Advisory for safe home isolation amid Omicron wave | Lifestyle News,The Indian Express

domingo, 23 de enero de 2022

Specific PHGKB|Rare Diseases PHGKB|PHGKB

Specific PHGKB|Rare Diseases PHGKB|PHGKB

Specific PHGKB|Neurological Disorders PHGKB|PHGKB

Specific PHGKB|Neurological Disorders PHGKB|PHGKB

Specific PHGKB|Infectious Diseases|PHGKB

Specific PHGKB|<bean:write name="specificPHGKBForm" property="topic" />|PHGKB

Specific PHGKB|Heart, Lung, Blood and Sleep Diseases|PHGKB

Specific PHGKB|HLBS|PHGKB

Specific PHGKB|Family Health History PHGKB|PHGKB

Specific PHGKB|Family Health History PHGKB|PHGKB

Specific PHGKB|Diabetes PHGKB|PHGKB

Specific PHGKB|Diabetes PHGKB|PHGKB

Specific PHGKB|Cancer|PHGKB

Specific PHGKB|Cancer|PHGKB

CDC-Authored Publications Update|PHGKB

CDC-Authored Publications Update|PHGKB

Precision Health Database| Non-Genomics Precision Health Weekly Scan|PHGKB

Precision Health Database| Non-Genomics Precision Health Weekly Scan|PHGKB

Advanced Molecular Detection Clips Database|AMD Clips|PHGKB

Advanced Molecular Detection Clips Database|AMD Clips|PHGKB

Precision Health Database| Genomics Precision Health Weekly Scan|PHGKB

Precision Health Database| Genomics Precision Health Weekly Scan|PHGKB

A Mini-Symposium: Implementing Precision and Equitable Public Health in Cascade Testing for Genetic Disorders | CDC

A Mini-Symposium: Implementing Precision and Equitable Public Health in Cascade Testing for Genetic Disorders | CDC

CDC-Authored Genomics and Precision Health Publications Database|Home|PHGKB

CDC-Authored Genomics and Precision Health Publications Database|Home|PHGKB

Genomics & Health Impact Scan Database|Search|PHGKB

Genomics & Health Impact Scan Database|Search|PHGKB

An Expanding List of Tier 1 Genomic Applications: Evidence-based Guidelines for Hypertrophic Cardiomyopathy and Public Health | Blogs | CDC

An Expanding List of Tier 1 Genomic Applications: Evidence-based Guidelines for Hypertrophic Cardiomyopathy and Public Health | Blogs | CDC

Hypertrophic Cardiomyopathy and Public Health: An Expanding List of Tier 1 Genomic Applications | CDC

Hypertrophic Cardiomyopathy and Public Health: An Expanding List of Tier 1 Genomic Applications | CDC

sábado, 22 de enero de 2022

Omicron Surge Is Undermining Care for Other Health Problems

Omicron Surge Is Undermining Care for Other Health Problems

Long COVID Associated With Risk of Metabolic Liver Disease

Long COVID Associated With Risk of Metabolic Liver Disease

FDA Approves Risankizumab (Skyrizi) for Psoriatic Arthritis

FDA Approves Risankizumab (Skyrizi) for Psoriatic Arthritis

Survival Improving in Sports-Related Sudden Cardiac Arrest

Survival Improving in Sports-Related Sudden Cardiac Arrest

COVID May Affect Spinal Fluid, Causing 'Brain Fog,' Study Says

COVID May Affect Spinal Fluid, Causing 'Brain Fog,' Study Says

Long COVID and self-management - The Lancet

Long COVID and self-management - The Lancet

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - The Lancet

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - The Lancet

COVID-19 Resource Centre

COVID-19 Resource Centre

The impact of multiple non-pharmaceutical interventions on controlling COVID-19 outbreak without lockdown in Hong Kong: A modelling study - The Lancet Regional Health – Western Pacific

The impact of multiple non-pharmaceutical interventions on controlling COVID-19 outbreak without lockdown in Hong Kong: A modelling study - The Lancet Regional Health – Western Pacific

Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19 - The Lancet Regional Health – Western Pacific

Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19 - The Lancet Regional Health – Western Pacific

SARS-CoV-2 outbreaks in hospitals and long-term care facilities in Germany: a national observational study - The Lancet Regional Health – Europe

SARS-CoV-2 outbreaks in hospitals and long-term care facilities in Germany: a national observational study - The Lancet Regional Health – Europe

Dynamic changes of pulmonary diffusion capacity in survivors of non-critical COVID-19 during the first six months - EClinicalMedicine

Dynamic changes of pulmonary diffusion capacity in survivors of non-critical COVID-19 during the first six months - EClinicalMedicine

Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs - EBioMedicine

Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs - EBioMedicine

Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers - EBioMedicine

Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers - EBioMedicine

Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease - The Lancet Rheumatology

Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease - The Lancet Rheumatology

Systemic sclerosis and COVID-19 vaccines: a SPIN Cohort study - The Lancet Rheumatology

Systemic sclerosis and COVID-19 vaccines: a SPIN Cohort study - The Lancet Rheumatology

Public mental health: required actions to address implementation failure in the context of COVID-19 - The Lancet Psychiatry

Public mental health: required actions to address implementation failure in the context of COVID-19 - The Lancet Psychiatry

The SARS-CoV2 pandemic and routine immunisation - The Lancet Global Health

The SARS-CoV2 pandemic and routine immunisation - The Lancet Global Health

COVID-19 will continue but the end of the pandemic is near - The Lancet

COVID-19 will continue but the end of the pandemic is near - The Lancet

Offline: COVID-19 as culture war - The Lancet

Offline: COVID-19 as culture war - The Lancet

Trimeric S protein COVID-19 vaccine needs to find its place - The Lancet

Trimeric S protein COVID-19 vaccine needs to find its place - The Lancet

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial - The Lancet

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial - The Lancet

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study - The Lancet

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study - The Lancet

HIVinfo | Information on HIV/AIDS Treatment, Prevention and Research | NIH

HIVinfo | Information on HIV/AIDS Treatment, Prevention and Research | NIH

Researchers highlight COVID-19 neurological symptoms and need for rigorous studies | National Institutes of Health (NIH)

Researchers highlight COVID-19 neurological symptoms and need for rigorous studies | National Institutes of Health (NIH)

Millions are dying from drug-resistant infections, global report says - BBC News

Millions are dying from drug-resistant infections, global report says - BBC News

Deltacron: the story of the variant that wasn’t

Deltacron: the story of the variant that wasn’t

What's New in the Guidelines? | NIH

What's New in the Guidelines? | NIH

Oral immunotherapy induces remission of peanut allergy in some young children | National Institutes of Health (NIH)

Oral immunotherapy induces remission of peanut allergy in some young children | National Institutes of Health (NIH)

How mRNA Vaccines Might Help Treat Cancer - National Cancer Institute

How mRNA Vaccines Might Help Treat Cancer - National Cancer Institute

RCC: nivolumab plus cabozantinib improves QoL

RCC: nivolumab plus cabozantinib improves QoL

Triglyceride-glucose index and lung cancer: is there a link?

Triglyceride-glucose index and lung cancer: is there a link?

Risk for pancreatic cancer in patients with small cysts

Risk for pancreatic cancer in patients with small cysts

Bempedoic acid lowers LDL-C without worsening glycemia

Bempedoic acid lowers LDL-C without worsening glycemia

New metabolic phenotype of long COVID identified

New metabolic phenotype of long COVID identified

FDA Takes Actions to Expand Use of Treatment for Outpatients with Mild-to-Moderate COVID-19 | FDA

FDA Takes Actions to Expand Use of Treatment for Outpatients with Mild-to-Moderate COVID-19 | FDA

viernes, 21 de enero de 2022

A comprehensive analysis places antimicrobial resistance among leading causes of death globally

A comprehensive analysis places antimicrobial resistance among leading causes of death globally

Vital Signs: MedlinePlus

Vital Signs: MedlinePlus

Skin Pigmentation Disorders | Hyperpigmentation | MedlinePlus

Skin Pigmentation Disorders | Hyperpigmentation | MedlinePlus

COVIDtests.gov - Free at-home COVID-19 tests

COVIDtests.gov - Free at-home COVID-19 tests

Vulvar Cancer Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Vulvar Cancer Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Mycosis Fungoides (Including Sézary Syndrome) Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Mycosis Fungoides (Including Sézary Syndrome) Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Malignant Mesothelioma Treatment (Adult) (PDQ®)–Health Professional Version - National Cancer Institute

Malignant Mesothelioma Treatment (Adult) (PDQ®)–Health Professional Version - National Cancer Institute

Levels of Evidence for Cancer Screening and Prevention Studies (PDQ®)–Health Professional Version - National Cancer Institute

Levels of Evidence for Cancer Screening and Prevention Studies (PDQ®)–Health Professional Version - National Cancer Institute

Hairy Cell Leukemia Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Hairy Cell Leukemia Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Depression (PDQ®)–Health Professional Version - National Cancer Institute

Depression (PDQ®)–Health Professional Version - National Cancer Institute

Curcumin (Curcuma, Turmeric) and Cancer (PDQ®)–Health Professional Version - National Cancer Institute

Curcumin (Curcuma, Turmeric) and Cancer (PDQ®)–Health Professional Version - National Cancer Institute

Chronic Myelogenous Leukemia Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Chronic Myelogenous Leukemia Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Invasive Ductal Carcinoma: Image Details - NCI Visuals Online

Invasive Ductal Carcinoma: Image Details - NCI Visuals Online

Opportunity for Public Comment | United States Preventive Services Taskforce: Public Comment on Draft Research Plan: Screening for Speech and Language Delay and Disorders in Children Age 5 Years or Younger

Opportunity for Public Comment | United States Preventive Services Taskforce

Extremely potent monoclonal antibodies neutralize Omicron and other SARS-CoV-2 variants | medRxiv

Extremely potent monoclonal antibodies neutralize Omicron and other SARS-CoV-2 variants | medRxiv

COVID-19 vaccination does not reduce chances of conception, study suggests | National Institutes of Health (NIH)

COVID-19 vaccination does not reduce chances of conception, study suggests | National Institutes of Health (NIH)

New data show continued decline in death rates for cancer patients related to treatment advances

New data show continued decline in death rates for cancer patients related to treatment advances

jueves, 20 de enero de 2022

List of the latest marketing authorisations and orphan medicinal products designations | www.eurordis.org

List of the latest marketing authorisations and orphan medicinal products designations | www.eurordis.org

General discussion: Updates

General discussion: Updates

FINAL - 40th Anniversary Report Metabolic Support UK

FINAL - 40th Anniversary Report Metabolic Support UK

Invisible Manners - a short film on invisible conditions | NPUK

COVID-19 and rare diseases: reflections and recommendations by the International Rare Diseases Research Consortium

COVID-19 and rare diseases: reflections and recommendations by the International Rare Diseases Research Consortium

Frontiers | Repurposing of Medicines in the EU: Launch of a Pilot Framework | Medicine

Frontiers | Repurposing of Medicines in the EU: Launch of a Pilot Framework | Medicine

EURORDIS-Rare Diseases Europe welcomes France’s commitment to Europe’s Action Plan for Rare Diseases during its Presidency of the Council of the European Union - EURORDIS - The Voice of Rare Disease Patients in Europe

EURORDIS - The Voice of Rare Disease Patients in Europe

#LightUpForRare – Rare Disease Day 2022

#LightUpForRare – Rare Disease Day 2022

The Members and Volunteers who are changing lives of people living with a rare disease: meet the 2022 Black Pearl Awardees - EURORDIS - The Voice of Rare Disease Patients in Europe

EURORDIS - The Voice of Rare Disease Patients in Europe

Fee-waivers - ECRD2022 - EUROPEAN CONFERENCE ON RARE DISEASES & ORPHAN PRODUCTS

Fee-waivers - ECRD2022

Towards a revised EU’s general pharmaceuticals legislation: emerging perspectives for improving the treatment of rare diseases - EURORDIS - The Voice of Rare Disease Patients in Europe

EURORDIS - The Voice of Rare Disease Patients in Europe

Special New Year's message from EURORDIS Chief Executive Officer, Yann Le Cam - EURORDIS - The Voice of Rare Disease Patients in Europe

EURORDIS - The Voice of Rare Disease Patients in Europe

Omicron thwarts some of the world’s most-used COVID vaccines

Omicron thwarts some of the world’s most-used COVID vaccines

‘Nocebo effect’: two-thirds of Covid jab reactions not caused by vaccine, study suggests | Medical research | The Guardian

‘Nocebo effect’: two-thirds of Covid jab reactions not caused by vaccine, study suggests | Medical research | The Guardian

Surgery for Ovarian Cancer | E-Cigs | Nicotine Withdrawal, 01/19/2022

Surgery for Ovarian Cancer | E-Cigs | Nicotine Withdrawal, 01/19/2022

NCCIH | NCCIH

NCCIH | NCCIH

ICMR approves new RT-PCR kit that detects Omicron variant in 45 minutes; know more | Lifestyle News,The Indian Express

ICMR approves new RT-PCR kit that detects Omicron variant in 45 minutes; know more | Lifestyle News,The Indian Express

Delhi News Live Updates 20 January 2022: Delhi Weekend Curfew News, Delhi-NCR Omicron Covid-19 Cases Latest Update Live, Delhi Weather, COVID-19 Travel Rules, Delhi Lockdown Updates, Delhi Curfew Rules, Weather Today Latest News

Delhi News Live Updates 20 January 2022: Delhi Weekend Curfew News, Delhi-NCR Omicron Covid-19 Cases Latest Update Live, Delhi Weather, COVID-19 Travel Rules, Delhi Lockdown Updates, Delhi Curfew Rules, Weather Today Latest News

Omicron Coronavirus India Live News, January 20, 2022: 2.8 lakh daily cases in India; PM Modi lauds youngsters

Omicron Coronavirus India Live News, January 20, 2022: 2.8 lakh daily cases in India; PM Modi lauds youngsters

Taiwan nurtures new Israeli health, cyber, energy firms - ISRAEL21c

Taiwan nurtures new Israeli health, cyber, energy firms - ISRAEL21c

Magen David Adom CEO takes shifts at Covid testing sites - ISRAEL21c

Magen David Adom CEO takes shifts at Covid testing sites - ISRAEL21c

New method quickly, efficiently removes toxins from water - ISRAEL21c

New method quickly, efficiently removes toxins from water - ISRAEL21c

Israel finds 4th vaccine dose not as effective vs. Omicron - ISRAEL21c

Israel finds 4th vaccine dose not as effective vs. Omicron - ISRAEL21c

Keto diet may reduce damage from traumatic brain injury - ISRAEL21c

Keto diet may reduce damage from traumatic brain injury - ISRAEL21c

miércoles, 19 de enero de 2022

Study shows green Med diet slows age-related brain atrophy - ISRAEL21c

Study shows green Med diet slows age-related brain atrophy - ISRAEL21c

Revolutionary implant could ease congestive heart failure - ISRAEL21c

Revolutionary implant could ease congestive heart failure - ISRAEL21c

New therapies for AIRDs can reduce the harmful side-effects caused by conventional treatments

New therapies for AIRDs can reduce the harmful side-effects caused by conventional treatments

Fourth Vaccine Shot Less Effective Against Omicron

Fourth Vaccine Shot Less Effective Against Omicron

Study reports of receptor-binding domain multimer capable of enhancing the immune response against SARS-CoV-2

Study reports of receptor-binding domain multimer capable of enhancing the immune response against SARS-CoV-2

Implications of higher viral load in new SARS-CoV-2 variants on airborne transmission

Implications of higher viral load in new SARS-CoV-2 variants on airborne transmission

Symptoms Common in High-Risk, Early-Stage Ovarian Cancer

Symptoms Common in High-Risk, Early-Stage Ovarian Cancer

HEALTH OF WOMEN CENTER FOR DEVICES & RADIOLOGICAL HEALTH

HEALTH OF WOMEN CENTER FOR DEVICES & RADIOLOGICAL HEALTH

Offering buprenorphine medication to people with opioid use disorder in jail may reduce rearrest and reconviction | National Institutes of Health (NIH)

Offering buprenorphine medication to people with opioid use disorder in jail may reduce rearrest and reconviction | National Institutes of Health (NIH)

Are plaque deposits in the brain the true cause of Alzheimer’s disease? - Genetic Literacy Project

Are plaque deposits in the brain the true cause of Alzheimer’s disease? - Genetic Literacy Project

Eye Conditions at a Glance | NCCIH

Eye Conditions at a Glance | NCCIH

Covid-19 health emergency could be over this year, WHO says | World News,The Indian Express

Covid-19 health emergency could be over this year, WHO says | World News,The Indian Express

Covid-19 update: Slight uptick in India’s daily cases; Delhi, Mumbai show decline | India News,The Indian Express

Covid-19 update: Slight uptick in India’s daily cases; Delhi, Mumbai show decline | India News,The Indian Express

Adar Poonawalla: ‘Billions need to be vaccinated at a faster rate for Covid pandemic to end’ | Cities News,The Indian Express

Adar Poonawalla: ‘Billions need to be vaccinated at a faster rate for Covid pandemic to end’ | Cities News,The Indian Express

Omicron Coronavirus India Live News, January 19, 2022: 2.8 lakh daily cases in India; PM Modi lauds youngsters

Omicron Coronavirus India Live News, January 19, 2022: 2.8 lakh daily cases in India; PM Modi lauds youngsters

Covid-19 Omicron wave reinfections: Is there a limit?

Covid-19 Omicron wave reinfections: Is there a limit?

martes, 18 de enero de 2022

How One Change to The Coronavirus Spike Influences Infectivity – NIH Director's Blog

How One Change to The Coronavirus Spike Influences Infectivity – NIH Director's Blog

Survival rate increases for extremely preterm infants in NIH-funded research network | National Institutes of Health (NIH)

Survival rate increases for extremely preterm infants in NIH-funded research network | National Institutes of Health (NIH)

SARS-CoV-2 may cause fetal inflammation even in the absence of placental infection | National Institutes of Health (NIH)

SARS-CoV-2 may cause fetal inflammation even in the absence of placental infection | National Institutes of Health (NIH)

The pandemic’s true death toll: millions more than official counts

The pandemic’s true death toll: millions more than official counts

Higher Cardiorespiratory Fitness Cuts Incident Diabetes Risk

Higher Cardiorespiratory Fitness Cuts Incident Diabetes Risk

New Links on MedlinePlus

New Links on MedlinePlus

Comparison of antibody responses and vaccine effectiveness in healthcare workers post-primary COVID-19 vaccination

Comparison of antibody responses and vaccine effectiveness in healthcare workers post-primary COVID-19 vaccination

Exploring SARS-CoV-2 Omicron variant’s neutralizing capacity of booster vaccines

Exploring SARS-CoV-2 Omicron variant’s neutralizing capacity of booster vaccines

Study reveals a causal link between deficiency in Parkinson’s disease gene and reduced immunoaging

Study reveals a causal link between deficiency in Parkinson’s disease gene and reduced immunoaging

Forecasting the temporal evolution of Omicron infections

Forecasting the temporal evolution of Omicron infections

A clinical case definition of post-COVID-19 condition by a Delphi consensus - The Lancet Infectious Diseases

A clinical case definition of post-COVID-19 condition by a Delphi consensus - The Lancet Infectious Diseases

How do death rates from COVID-19 differ between people who are vaccinated and those who are not? - Our World in Data

How do death rates from COVID-19 differ between people who are vaccinated and those who are not? - Our World in Data

COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021 | MMWR

COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021 | MMWR

Unvaccinated pregnant people are at higher risk for Covid complications

Unvaccinated pregnant people are at higher risk for Covid complications

Omicron Is Forcing Us to Rethink Mild COVID - The Atlantic

Omicron Is Forcing Us to Rethink Mild COVID - The Atlantic

Covid-19: Is it safe to reduce the self-isolation period? | The BMJ

Covid-19: Is it safe to reduce the self-isolation period? | The BMJ

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines | NEJM

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines | NEJM

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial - The Lancet Infectious Diseases

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial - The Lancet Infectious Diseases

Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA Network Open | JAMA Network

Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA Network Open | JAMA Network

Perioperative Cardiovascular Considerations Prior to Elective Noncardiac Surgery in Patients With a History of COVID-19 | Surgery | JAMA Surgery | JAMA Network

Perioperative Cardiovascular Considerations Prior to Elective Noncardiac Surgery in Patients With a History of COVID-19 | Surgery | JAMA Surgery | JAMA Network

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial - The Lancet

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial - The Lancet

lunes, 17 de enero de 2022

Journal of Experimental & Clinical Cancer Research | Home page

Journal of Experimental & Clinical Cancer Research | Home page

Inflammation and Regeneration | Home

Inflammation and Regeneration | Home

Human Genomics | Home page

Human Genomics | Home page

Hereditary Cancer in Clinical Practice | Home page

Hereditary Cancer in Clinical Practice | Home page

Genome Medicine | Home page

Genome Medicine | Home page

Fluids and Barriers of the CNS | Home page

Fluids and Barriers of the CNS | Home page

Epigenetics Communications | Home

Epigenetics Communications | Home

Clinical Epigenetics | Home page

Clinical Epigenetics | Home page

Cancer Cell International | Home page

Cancer Cell International | Home page

Cancer & Metabolism | Home page

Cancer & Metabolism | Home page

Breast Cancer Research | Home page

Breast Cancer Research | Home page

BMC Research Notes | Home page

BMC Research Notes | Home page

BMC Pharmacology and Toxicology | Home page

BMC Pharmacology and Toxicology | Home page

BMC Neuroscience | Home page

BMC Neuroscience | Home page

BMC Medical Genomics | Home page

BMC Medical Genomics | Home page

BMC Immunology | Home page

BMC Immunology | Home page

BMC Cancer | Home page

BMC Cancer | Home page

Biology of Sex Differences | Home page

Biology of Sex Differences | Home page

Behavioral and Brain Functions | Home page

Behavioral and Brain Functions | Home page

Alzheimer's Research & Therapy | Home page

Alzheimer's Research & Therapy | Home page

Acta Neuropathologica Communications | Home page

Acta Neuropathologica Communications | Home page

Orphanet Journal of Rare Diseases | Home page

Orphanet Journal of Rare Diseases | Home page

Cervical Cancer Awareness Month: Four things every woman should know | Lifestyle News,The Indian Express

Cervical Cancer Awareness Month: Four things every woman should know | Lifestyle News,The Indian Express

As India completes year of vaccination, govt tells SC: No forced jabs, vaccine certificate not a must | India News,The Indian Express

As India completes year of vaccination, govt tells SC: No forced jabs, vaccine certificate not a must | India News,The Indian Express

domingo, 16 de enero de 2022

Specific PHGKB|Rare Diseases PHGKB|PHGKB

Specific PHGKB|Rare Diseases PHGKB|PHGKB

Specific PHGKB|Neurological Disorders PHGKB|PHGKB

Specific PHGKB|Neurological Disorders PHGKB|PHGKB

Specific PHGKB|Infectious Diseases|PHGKB

Specific PHGKB|<bean:write name="specificPHGKBForm" property="topic" />|PHGKB

Specific PHGKB|Heart, Lung, Blood and Sleep Diseases|PHGKB

Specific PHGKB|HLBS|PHGKB

Specific PHGKB|Family Health History PHGKB|PHGKB

Specific PHGKB|Family Health History PHGKB|PHGKB

Specific PHGKB|Diabetes PHGKB|PHGKB

Specific PHGKB|Diabetes PHGKB|PHGKB

Specific PHGKB|Cancer|PHGKB

Specific PHGKB|Cancer|PHGKB

CDC-Authored Publications Update|PHGKB

CDC-Authored Publications Update|PHGKB

Precision Health Database| Non-Genomics Precision Health Weekly Scan|PHGKB

Precision Health Database| Non-Genomics Precision Health Weekly Scan|PHGKB

Advanced Molecular Detection Clips Database|AMD Clips|PHGKB

Advanced Molecular Detection Clips Database|AMD Clips|PHGKB

Precision Health Database| Genomics Precision Health Weekly Scan|PHGKB

Precision Health Database| Genomics Precision Health Weekly Scan|PHGKB

COVID-19 GPH|Home|PHGKB

COVID-19 GPH|Home|PHGKB

Progress in Genomic Medicine Implementation: Research Priorities and Population Health Impact | CDC

Progress in Genomic Medicine Implementation: Research Priorities and Population Health Impact | CDC

Awareness of Birth Defects Across the Lifespan | CDC

Awareness of Birth Defects Across the Lifespan | CDC

CDC-Authored Genomics and Precision Health Publications Database|Home|PHGKB

CDC-Authored Genomics and Precision Health Publications Database|Home|PHGKB

The Current Landscape of CDC Publications in Human Genomics and Public Health | Blogs | CDC

The Current Landscape of CDC Publications in Human Genomics and Public Health | Blogs | CDC

sábado, 15 de enero de 2022

Epstein-Barr Virus a Likely Leading Cause of Multiple Sclerosis

Epstein-Barr Virus a Likely Leading Cause of Multiple Sclerosis

Almost All Teens in ICU With COVID Were Unvaccinated, Study Shows

Almost All Teens in ICU With COVID Were Unvaccinated, Study Shows

COVID-19 and Acute Coronary Syndrome: Lessons for Everyone - The Lancet Regional Health – Western Pacific

COVID-19 and Acute Coronary Syndrome: Lessons for Everyone - The Lancet Regional Health – Western Pacific

Impact of the coronavirus disease 2019 interventions on the incidence of hand, foot, and mouth disease in mainland China - The Lancet Regional Health – Western Pacific

Impact of the coronavirus disease 2019 interventions on the incidence of hand, foot, and mouth disease in mainland China - The Lancet Regional Health – Western Pacific

Quantitative plasma proteome profiling of COVID-19 patients with mild and moderate symptoms - EBioMedicine

Quantitative plasma proteome profiling of COVID-19 patients with mild and moderate symptoms - EBioMedicine

CRISPRi links COVID-19 GWAS loci to LZTFL1 and RAVER1 - EBioMedicine

CRISPRi links COVID-19 GWAS loci to LZTFL1 and RAVER1 - EBioMedicine

Lack of evidence of significant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens - EBioMedicine

Lack of evidence of significant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens - EBioMedicine

Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice - EBioMedicine

Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice - EBioMedicine

Affinity of anti-spike antibodies in SARS-CoV-2 patient plasma and its effect on COVID-19 antibody assays - EBioMedicine

Affinity of anti-spike antibodies in SARS-CoV-2 patient plasma and its effect on COVID-19 antibody assays - EBioMedicine

Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial - EBioMedicine

Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial - EBioMedicine

Mucosal immune response in BNT162b2 COVID-19 vaccine recipients - EBioMedicine

Mucosal immune response in BNT162b2 COVID-19 vaccine recipients - EBioMedicine

Accuracy and ease-of-use of seven point-of-care SARS-CoV-2 antigen-detecting tests: A multi-centre clinical evaluation - EBioMedicine

Accuracy and ease-of-use of seven point-of-care SARS-CoV-2 antigen-detecting tests: A multi-centre clinical evaluation - EBioMedicine

Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study - The Lancet Respiratory Medicine

Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study - The Lancet Respiratory Medicine

Pregnancy and SARS-CoV-2: an opportunity to systematically study the complexity of maternal health - The Lancet Digital Health

Pregnancy and SARS-CoV-2: an opportunity to systematically study the complexity of maternal health - The Lancet Digital Health

The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study - The Lancet Digital Health

The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study - The Lancet Digital Health

The power of resilience - The Lancet Diabetes & Endocrinology

The power of resilience - The Lancet Diabetes & Endocrinology

Ground glass opacities are not always COVID-19: a case of acute eosinophilic pneumonitis caused by daptomycin - The Lancet

Ground glass opacities are not always COVID-19: a case of acute eosinophilic pneumonitis caused by daptomycin - The Lancet

25 Years of the Office of Cancer Survivorship | Former DCCPS Director, D...

Extrapolation of Efficacy and Dose Selection in Pediatrics: A Case Example of Atypical Antipsychotics in Adolescents With Schizophrenia and Bipolar I Disorder - Kalaria - 2021 - The Journal of Clinical Pharmacology - Wiley Online Library

Extrapolation of Efficacy and Dose Selection in Pediatrics: A Case Example of Atypical Antipsychotics in Adolescents With Schizophrenia and Bipolar I Disorder - Kalaria - 2021 - The Journal of Clinical Pharmacology - Wiley Online Library

REXULTI (brexpiprazole) tablets, for oral use

REXULTI (brexpiprazole) tablets, for oral use

viernes, 14 de enero de 2022

Oral Buprenorphine Tied to Severe Tooth Decay, FDA Warns

Oral Buprenorphine Tied to Severe Tooth Decay, FDA Warns

Epstein-Barr Virus a Likely Leading Cause of Multiple Sclerosis

Epstein-Barr Virus a Likely Leading Cause of Multiple Sclerosis

How has COVID-19 Impacted our Economy?

How has COVID-19 Impacted our Economy?

Personal Information - 2021-2022 Principles of Pediatric Clinical Pharmacology and Therapeutics Course

Personal Information - 2021-2022 Principles of Pediatric Clinical Pharmacology and Therapeutics Course FDA Announces Upcoming Principles of Pediatric Clinical Pharmacology Lecture Series The 2021-2022 Principles of Pediatric Clinical Pharmacology lecture series offered by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) resumed on January 5, 2022. Two upcoming U.S. Food and Drug Administration (FDA) roundtable discussions will be presented as a part of this series: February 16, 2022: FDA Roundtable Discussion on Systems Pharmacology April 6, 2022: FDA Roundtable Discussion on Pharmacometrics and Clinical Trials Design This lecture series is designed to address the fundamentals of clinical pharmacology from a pediatric perspective. 1.00 AMA PRA Category 1 Credits™ are available for each lecture. Registration is free and open to the public. Lectures are given via live webinar in Adobe Connect on Wednesdays from 12:00 PM to 1:00 PM ET. Login details are emailed to course registrants before each webinar. You are welcome to attend these and all other webinars in the course, as well as to share the links below with any interested trainees or colleagues. To register, visit https://cvent.me/Vng9ve. To view the course schedule, visit https://cvent.me/OmbxdR. For additional information, please contact pharmcourse@infinityconferences.com.

COVID vaccines safely protect pregnant people: the data are in

COVID vaccines safely protect pregnant people: the data are in

New Issue of NCCIH Update: New Opportunities for Advancing Pain Science; New NIH HEAL Funding Opportunities

New Issue of NCCIH Update: New Opportunities for Advancing Pain Science; New NIH HEAL Funding Opportunities

Flu, Cold, Allergies or COVID-19? | Cervical Cancer | 2021 Research Highlights | HIV & Substance Use | When To Test

Flu, Cold, Allergies or COVID-19? | Cervical Cancer | 2021 Research Highlights | HIV & Substance Use | When To Test

Final Research Plan: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce

Final Research Plan: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce

New Report: Nearly 800 new medicines in development to treat rare diseases

New Report: Nearly 800 new medicines in development to treat rare diseases

Do COVID-19 vaccines prevent viral transmission?

Do COVID-19 vaccines prevent viral transmission?

COVID-19: association between myocarditis and mortality

COVID-19: association between myocarditis and mortality

COVID-19: immune dysfunction linked to higher rate of breakthrough infection postvaccination

COVID-19: immune dysfunction linked to higher rate of breakthrough infection postvaccination

EMA approves anakinra for COVID-19

EMA approves anakinra for COVID-19

Sperm quality after COVID-19 infection

Sperm quality after COVID-19 infection

CORBEVAX: Could this vaccine corral COVID in the developing world? - Genetic Literacy Project

CORBEVAX: Could this vaccine corral COVID in the developing world? - Genetic Literacy Project

jueves, 13 de enero de 2022

The COVID generation: how is the pandemic affecting kids’ brains?

The COVID generation: how is the pandemic affecting kids’ brains?

‘Killer’ immune cells still recognize Omicron variant

‘Killer’ immune cells still recognize Omicron variant

SARS-CoV-2-specific immune responses elicited by inactivated COVID-19 vaccines

SARS-CoV-2-specific immune responses elicited by inactivated COVID-19 vaccines

Exploring healthcare workers' opinions on mandatory COVID-19 vaccination in the UK

Exploring healthcare workers' opinions on mandatory COVID-19 vaccination in the UK

Using lab-grown stomachs to shed light on the symptoms of COVID-19

Using lab-grown stomachs to shed light on the symptoms of COVID-19

HRSA Updates the Affordable Care Act Preventive Health Care Guidelines to Improve Care for Women and Children | HIV.gov

HRSA Updates the Affordable Care Act Preventive Health Care Guidelines to Improve Care for Women and Children | HIV.gov

An integrated approach to address perinatal mental health treatment - Children's National

An integrated approach to address perinatal mental health treatment - Children's National

GABA and glutamate in the preterm neonatal brain - Children's National

GABA and glutamate in the preterm neonatal brain - Children's National

How to Make Sense of Omicron and Changing COVID Protocols

How to Make Sense of Omicron and Changing COVID Protocols

More Reassurance on LDL Lowering and ICH After Stroke

More Reassurance on LDL Lowering and ICH After Stroke

CDC to Update Mask Recommendations as Omicron Spreads

CDC to Update Mask Recommendations as Omicron Spreads

Why Getting COVID on Purpose Is a Dangerous Idea

Why Getting COVID on Purpose Is a Dangerous Idea

https://medlineplus.gov/ency/patientinstructions/000419.htm?utm_source=newsletter&utm_campaign=jan12

https://medlineplus.gov/ency/patientinstructions/000419.htm?utm_source=newsletter&utm_campaign=jan12

Strabismus: MedlinePlus Medical Encyclopedia

Strabismus: MedlinePlus Medical Encyclopedia

Calcium - Consumer

Calcium - Consumer

mRNA research may lead to better cancer drugs - ISRAEL21c

mRNA research may lead to better cancer drugs - ISRAEL21c

A book-filled childhood prevents later cognitive decline - ISRAEL21c

A book-filled childhood prevents later cognitive decline - ISRAEL21c

Why I got the fourth Covid-19 shot, despite my ambivalence - ISRAEL21c

Why I got the fourth Covid-19 shot, despite my ambivalence - ISRAEL21c

New targeted therapy could treat lupus nephritis - ISRAEL21c

New targeted therapy could treat lupus nephritis - ISRAEL21c

AI technology helps identify patients at risk from sepsis - ISRAEL21c

AI technology helps identify patients at risk from sepsis - ISRAEL21c

The answer to Parkinson’s and Alzheimer’s is all in your eyes - ISRAEL21c

The answer to Parkinson’s and Alzheimer’s is all in your eyes - ISRAEL21c

Nutrition in adolescent growth and development - The Lancet

Nutrition in adolescent growth and development - The Lancet

Food choice in transition: adolescent autonomy, agency, and the food environment - The Lancet

Food choice in transition: adolescent autonomy, agency, and the food environment - The Lancet

Strategies and interventions for healthy adolescent growth, nutrition, and development - The Lancet

Strategies and interventions for healthy adolescent growth, nutrition, and development - The Lancet

Adolescent nutrition

Adolescent nutrition

Surgery for Recurrent Ovarian Cancer May Help Selected Patients - National Cancer Institute

Surgery for Recurrent Ovarian Cancer May Help Selected Patients - National Cancer Institute

Global launch of the Lancet Neurology Series on autoimmune neuromuscular junction disorders

Global launch of the Lancet Neurology Series on autoimmune neuromuscular junction disorders

Clinical Realities: Eric Peters and Jinoos Yazdani on rheumatology care for undocumented immigrants

Clinical Realities: Eric Peters and Jinoos Yazdani on rheumatology care for undocumented immigrants

WHO calls for new Covid vaccines to combat emerging variants; here’s what experts say | Lifestyle News,The Indian Express

WHO calls for new Covid vaccines to combat emerging variants; here’s what experts say | Lifestyle News,The Indian Express

Frequent Covid-19 booster shots could adversely affect the immune response, warns health agency

Frequent Covid-19 booster shots could adversely affect the immune response, warns health agency

miércoles, 12 de enero de 2022

Prostate Cancer Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Prostate Cancer Treatment (PDQ®)–Health Professional Version - National Cancer Institute

Genetics of Endocrine and Neuroendocrine Neoplasias (PDQ®)–Health Professional Version - National Cancer Institute

Genetics of Endocrine and Neuroendocrine Neoplasias (PDQ®)–Health Professional Version - National Cancer Institute

Childhood Cancer Genomics (PDQ®)–Health Professional Version - National Cancer Institute

Childhood Cancer Genomics (PDQ®)–Health Professional Version - National Cancer Institute

NIH researchers develop first stem cell model of albinism to study related eye conditions | National Institutes of Health (NIH)

NIH researchers develop first stem cell model of albinism to study related eye conditions | National Institutes of Health (NIH)

When can we declare the COVID pandemic officially over? - Genetic Literacy Project

When can we declare the COVID pandemic officially over? - Genetic Literacy Project

MAPK4 may play a key role in triple-negative breast cancer

MAPK4 may play a key role in triple-negative breast cancer

New method for monitoring circulating SARS-CoV-2 variants and detecting new ones

New method for monitoring circulating SARS-CoV-2 variants and detecting new ones

Comparing the Moderna and Pfizer-Biontech vaccines against SARS-CoV-2 infection

Comparing the Moderna and Pfizer-Biontech vaccines against SARS-CoV-2 infection